Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

Registrieren

GRF Eagle Capital Growth Fund Inc

9,9157

0,00 (0,00%)

Vor Marktöffnung

Zuletzt aktualisiert: 10:09:34

Verzögert um 15 Minuten

Form 40-17G - Fidelity Bond [Rule 17G-1(g)]

Eagle Capital Growth (AMEX:GRF)
Historical Stock Chart
Von Dez 2024 bis Jan 2025

Click Here for more Eagle Capital Growth Charts.

Eagle Capital Growth (AMEX:GRF)
Historical Stock Chart
Von Jan 2024 bis Jan 2025

Click Here for more Eagle Capital Growth Charts.

News Eagle Capital Growth Fund Inc

Grifols Pioneers High-Tech Analysis of Plasma Bank to Detect Early Signs of Parkinson’s Disease
Dienstag 14 Januar 2025 (2 Wochen vor) • GlobeNewswire Inc.

Form 40-17G - Fidelity Bond [Rule 17G-1(g)]
Donnerstag 26 Dezember 2024 (1 Monat vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Donnerstag 5 Dezember 2024 (2 Monate vor) • Edgar (US Regulatory)

GigaGen Doses First Patient in Phase 1 Trial of Recombinant Polyclonal Drug Candidate, GIGA-2339, for Hepatitis B Virus
Dienstag 19 November 2024 (2 Monate vor) • GlobeNewswire Inc.

Eagle Capital Growth Fund Declares Year-End Distribution of $0.68 Per Share in Cash
Montag 18 November 2024 (2 Monate vor) • Business Wire

Grifols Receives FDA Approval to Treat Surgical Bleeding in Pediatric Patients With its Fibrin Sealant Solution
Dienstag 29 Oktober 2024 (3 Monate vor) • GlobeNewswire Inc.

Grifols Partners with BARDA for Proof-of-Concept Testing of Ocular Immunoglobulin as Treatment for Sulfur Mustard-Induced Eye Injury
Dienstag 22 Oktober 2024 (3 Monate vor) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Donnerstag 3 Oktober 2024 (4 Monate vor) • Edgar (US Regulatory)

GigaGen Awarded U.S. BARDA Contract to Develop Recombinant Polyclonal Antibody Therapies for Botulinum Neurotoxins and an Additional Biothreat
Donnerstag 3 Oktober 2024 (4 Monate vor) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Dienstag 10 September 2024 (5 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Dienstag 10 September 2024 (5 Monate vor) • Edgar (US Regulatory)

GigaGen Receives FDA Clearance of IND Application for Phase 1 Trial of Recombinant Polyclonal for HBV Treatment, GIGA-2339
Mittwoch 31 Juli 2024 (6 Monate vor) • GlobeNewswire Inc.

Weitere Eagle Capital Growth Fund Inc News-Artikel

Deutsche Lufthansa

Gold vs US Dollar

Euro vs Sterling

Health Care Select Sector

Deutsche Telekom (QX)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen